Yungang Lu - China Biologic Independent Director
Director
Dr. Yungang Lu is Independent Director of China Biologic Products, Inc. Dr. Lu has served as a managing director of Seres Asset Management Limited, an investment manager based in Hong Kong, since August 2009. Dr. Lu also serves as a director of the following listed companies China Techfaith Wireless Communication Technology Ltd., a handheld device company in China, and China Cord Blood Corporationrationration, a provider of cord blood storage services in China. From 2004 to July 2009, Dr. Lu was a Managing Director of APAC Capital Advisors Limited, a Hong Kongbased investment manager specializing in Greater China equities. Dr. Lu was a research analyst with Credit Suisse First Boston, a financial services company, from 1998 to 2004, where his last position was the head of China Research. Before moving to Credit Suisse, he worked as an equity analyst focused on regional infrastructure at JP Morgan Securities Asia, a financial services company, in Hong Kong since 2012.
Age | 52 |
Tenure | 12 years |
Phone | (86) 10 6598 3222 |
Web | www.chinabiologic.com |
China Biologic Management Efficiency
The company has return on total asset (ROA) of 5.82 % which means that it generated a profit of $5.82 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 9.25 %, meaning that it created $9.25 on every $100 dollars invested by stockholders. China Biologic's management efficiency ratios could be used to measure how well China Biologic manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Paula Madoff | Tradeweb Markets | 50 | |
Charles Sonsteby | Valvoline | 67 | |
Vada Manager | Valvoline | 59 | |
Mike Hussey | Tradeweb Markets | 46 | |
Robert Rowley | Tradeweb Markets | 66 | |
David Nelms | CDW Corp | 57 | |
Glenn Creamer | CDW Corp | 53 | |
Joseph Swedish | CDW Corp | 66 | |
Gerald Evans | Valvoline | 61 | |
Virginia Addicott | CDW Corp | 54 | |
Stephen Macadam | Valvoline | 60 | |
Robin Selati | CDW Corp | 49 | |
Lynda Clarizio | CDW Corp | 57 | |
Donna Zarcone | CDW Corp | 60 | |
Paul Finnegan | CDW Corp | 65 | |
Angela Knight | Tradeweb Markets | 64 | |
Virginia Albanese | CDW Corp | 51 | |
Steven Alesio | CDW Corp | 64 | |
James Jordan | Tradeweb Markets | 47 | |
Carol Kruse | Valvoline | 58 | |
Barry Allen | CDW Corp | 69 |
Management Performance
Return On Equity | 9.25 | |||
Return On Asset | 5.82 |
China Biologic Products Leadership Team
Elected by the shareholders, the China Biologic's board of directors comprises two types of representatives: China Biologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Biologic's management team and ensure that shareholders' interests are well served. China Biologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Biologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Min Fang, Director | ||
Zhijing Liu, Corporate VP | ||
Ming Yang, CFO | ||
Joseph Chow, Independent Director | ||
Gang Yang, Corporate VP and General Manager of Guizhou Taibang | ||
Xiaosheng Shao, Independent Director | ||
Ming Yin, Sr. Corporate VP and Corporate Secretary | ||
Zhijun Tong, Independent Director | ||
Yungang Lu, Independent Director | ||
Wenfang Liu, Independent Director | ||
Wai Yeung, Independent Director | ||
David Li, Director | ||
David Gao, Chairman of the Board and Presidentident, CEO | ||
Xiaoying Gao, Executive Chairman, CEO and Pres |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Biologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 9.25 | |||
Return On Asset | 5.82 | |||
Profit Margin | 29.04 % | |||
Operating Margin | 37.26 % | |||
Current Valuation | 3.56 B | |||
Shares Outstanding | 38.79 M | |||
Shares Owned By Insiders | 45.08 % | |||
Shares Owned By Institutions | 51.03 % | |||
Number Of Shares Shorted | 781.13 K | |||
Price To Earning | 31.41 X |
Pair Trading with China Biologic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Biologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Biologic will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to EOG Resources could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EOG Resources when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EOG Resources - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EOG Resources to buy it.
The correlation of EOG Resources is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EOG Resources moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EOG Resources moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EOG Resources can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in China Stock
If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |